Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required) vs National Paralysis Resource Center
Side-by-side comparison of two grants.
| Attribute | Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required) | National Paralysis Resource Center |
|---|---|---|
| Type | Grant | Grant |
| Funding amount | — | $10M |
| Deadline | Closes 2027-10-15 | Closes in 4 days |
| Region | US | US |
| Sector | Health | Health |
| Funder | National Institutes of Health | Administration for Community Living |
| Who it's for | researchers, government | individuals, nonprofits, government |